TVLine Items: Emily VanCamp’s New Show, Phillipa Soo Joins Ryan Murphy’s Dr. Odyssey and More

Keisha Hatchett
·2 min read
1
  • Oops!
    Something went wrong.
    Please try again later.

Emily VanCamp (The Resident, The Falcon and the Winter Soldier) will tackle intolerance with her next role.

The actress is set to lead Prejudice, a Canadian legal procedural from Celeste Parr (Hudson & Rex, This Life), our sister site Deadline reports.

More from TVLine

VanCamp will portray Liesl Wellington, a rising Toronto litigator whose life is upended when her past as a sex worker comes to light. Ostracized by her professional and personal circles, she launches her own law firm to defend those who’ve also been silenced and delegitimized.

The show currently isn’t attached to a network, but it is described as a “heartening legal drama that takes on all the forces that conspire to keep the underdog hidden, silent, unequal and without agency,” per Keren Shahar, CEO of Keshet International — one of the show’s distributors.

Ready for some more recent newsy nuggets? Well…

* Phillipa Soo joins previously announced cast members Joshua Jackson and Don Johnson in Dr. Odyssey, ABC’s upcoming drama from Ryan Murphy, according to Variety. Character details are currently unknown.

* The 31st Annual Screen Actors Guild Awards will take place on Sunday, February 23, 2025. The two-hour ceremony will stream live on Netflix at 8 p.m. (ET) / 5 p.m. (PT).

* Apple TV+ has greenlit Down Cemetery Road, based on the first novel by Mick Herron (Slow Horses) and starring Emma Thompson and Ruth Wilson. “When a house explodes in a quiet Oxford suburb and a girl disappears in the aftermath, neighbor Sarah Tucker becomes obsessed with finding her and enlists the help of private investigator Zoë Boehm,” reads the official synopsis. “Zoë and Sarah suddenly find themselves in a complex conspiracy that reveals that people long believed dead are still among the living, while the living are fast joining the dead.”

Best of TVLine

Get more from TVLine.com: Follow us on Twitter, Facebook, Newsletter